Literature DB >> 27720767

Eyes on systems pharmacology.

Yu Chen1, Timothy S Kern2, Philip D Kiser3, Krzysztof Palczewski4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27720767      PMCID： PMC5154905          DOI： 10.1016/j.phrs.2016.09.026

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN： 1043-6618            Impact factor:   7.658


× No keyword cloud information.
  6 in total

Review 1.  Systems Pharmacology Links GPCRs with Retinal Degenerative Disorders.

Authors:  Yu Chen; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-03-23       Impact factor: 13.820

Review 2.  Gene-environment interactions in human diseases.

Authors:  David J Hunter
Journal:  Nat Rev Genet       Date:  2005-04       Impact factor: 53.242

3.  Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration.

Authors:  Yu Chen; Grazyna Palczewska; Debarshi Mustafi; Marcin Golczak; Zhiqian Dong; Osamu Sawada; Tadao Maeda; Akiko Maeda; Krzysztof Palczewski
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

4.  Complex diseases require complex therapies.

Authors:  Ravi Iyengar
Journal:  EMBO Rep       Date:  2013-11-15       Impact factor: 8.807

5.  Mechanism of all-trans-retinal toxicity with implications for stargardt disease and age-related macular degeneration.

Authors:  Yu Chen; Kiichiro Okano; Tadao Maeda; Vishal Chauhan; Marcin Golczak; Akiko Maeda; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

6.  Synergistically acting agonists and antagonists of G protein-coupled receptors prevent photoreceptor cell degeneration.

Authors:  Yu Chen; Grazyna Palczewska; Ikuo Masuho; Songqi Gao; Hui Jin; Zhiqian Dong; Linn Gieser; Matthew J Brooks; Philip D Kiser; Timothy S Kern; Kirill A Martemyanov; Anand Swaroop; Krzysztof Palczewski
Journal:  Sci Signal       Date:  2016-07-26       Impact factor: 8.192
  6 in total
  12 in total

1.  Regulation of Adrenergic, Serotonin, and Dopamine Receptors to Inhibit Diabetic Retinopathy: Monotherapies versus Combination Therapies.

Authors:  Timothy S Kern; Yunpeng Du; Jie Tang; Chieh Allen Lee; Haitao Liu; Alyssa Dreffs; Henri Leinonen; David A Antonetti; Krzysztof Palczewski
Journal:  Mol Pharmacol       Date:  2021-08-15       Impact factor: 4.054

2.  A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets.

Authors:  Ming Hong; Sha Li; Ning Wang; Hor-Yue Tan; Fan Cheung; Yibin Feng
Journal:  Int J Mol Sci       Date:  2017-03-13       Impact factor: 5.923

3.  The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer's Disease.

Authors:  Haobin Cai; Yunxia Luo; Xin Yan; Peng Ding; Yujie Huang; Shuhuan Fang; Rong Zhang; Yunbo Chen; Zhouke Guo; Jiansong Fang; Qi Wang; Jun Xu
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

4.  A Mixture of U.S. Food and Drug Administration-Approved Monoaminergic Drugs Protects the Retina From Light Damage in Diverse Models of Night Blindness.

Authors:  Henri Leinonen; Elliot H Choi; Anthony Gardella; Vladimir J Kefalov; Krzysztof Palczewski
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-04-01       Impact factor: 4.799

5.  Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma.

Authors:  Wei Guo; Jihan Huang; Ning Wang; Hor-Yue Tan; Fan Cheung; Feiyu Chen; Yibin Feng
Journal:  Front Pharmacol       Date:  2019-10-09       Impact factor: 5.810

6.  Network Pharmacology Study of the Hepatoprotective Effects of Quercetin-Containing Traditional Chinese Medicine, Anoectochilus roxburghii, and Validation of Quercetin as an Anti-Liver Injury Agent in a Mouse Model of Liver Injury.

Authors:  Wei Lin; Yuhan Wu; Jingjing Wang; Han Lin; Xiuming Xu; Guanrong He; Bizhu He; Xiaokai Ma
Journal:  Med Sci Monit       Date:  2020-12-16

7.  Study on the Mechanism of Compound Kidney-Invigorating Granule for Osteoporosis based on Network Pharmacology and Experimental Verification.

Authors:  Hao Lv; Jiuxiang Wang; Yujun Zhu; Ting Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-04       Impact factor: 2.629

8.  Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses.

Authors:  Wenning Yang; Xiaoquan Jiang; Jingtong Liu; Dongying Qi; Zhiqiang Luo; Guohua Yu; Xueyan Li; Muli Sen; Hongjiao Chen; Wei Liu; Yang Liu; Guopeng Wang
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

9.  Integrating Constituents Absorbed into Blood, Network Pharmacology, and Quantitative Analysis to Reveal the Active Components in Rubus chingii var. suavissimus that Regulate Lipid Metabolism Disorder.

Authors:  Man-Jing Jiang; Wan-Fang Huang; Shuai Huang; Yi-Xiang Lu; Yong Huang; Pei-Lin Du; Yao-Hua Li; Lan-Lan Fan
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

10.  Shensong Yangxin Protects Against Metabolic Syndrome-Induced Ventricular Arrhythmias by Inhibiting Electrical Remodeling.

Authors:  Hong-Jie Yang; Bin Kong; Wei Shuai; Jing-Jing Zhang; He Huang
Journal:  Front Pharmacol       Date:  2020-07-09       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.